Life sciences investor Decheng Capital targets $700M for fifth fund

After $900 million and $500-plus million fund closures last week from Foresite Capital and JP Morgan, respectively, another firm wants to enter the upper echelons …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BioMarin Pharmaceutical Inc Patent: Adolescent PKU Treatment with AvPAL Variant

Share this article According to GlobalData’s company profile on BioMarin Pharmaceutical, Human telomerase RT biomarker was a key innovation area identified from patents. BioMarin Pharmaceutical‘s

April 22, 2024

MD Praises ‘Tampon Tim’; Olympian Practicing Rugby Over Medicine; Defining Death

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. Why is the Trump campaign calling Kamala Harris’ running mate

August 9, 2024

Lilly, Eisai and Biogen seek more specifics in FDA guidance on early Alzheimer’s disease

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.